Intranasal delivery of hMSC-derived supernatant for treatment of ischemic stroke by inhibiting the pro-inflammatory polarization of neutrophils
Abstract Background Stem cells utilized for ischemic stroke treatment often display unstable homing capabilities and diminished activity in vivo, limiting their neuroprotective efficacy. Furthermore, the optimal delivery route for stem cells remains undetermined. While the cytokines secreted by stem...
Saved in:
Main Authors: | Yixiang Jiang, Ning Wang, Jingyi Liu, Haoran Ren, Wenkang Jiang, Yanting Lei, Xidan Fu, Miao Hao, Xiujuan Lang, Yumei Liu, Xijun Liu, Rui Li, Hulun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Stem Cell Research & Therapy |
Online Access: | https://doi.org/10.1186/s13287-025-04172-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Theoretical and Practical Issues That Are Relevant When Scaling Up hMSC Microcarrier Production Processes
by: Valentin Jossen, et al.
Published: (2016-01-01) -
Macrophage-derived neutrophil chemotactic factor is involved in the neutrophil recruitment inhibitory activity present in the supernatants of LPS-stimulated macrophages
by: B. M. Tavares-Murta, et al.
Published: (1996-01-01) -
Recent Developed Strategies for Enhancing Chondrogenic Differentiation of MSC: Impact on MSC-Based Therapy for Cartilage Regeneration
by: Kangkang Zha, et al.
Published: (2021-01-01) -
Heterogeneity of MSC: Origin, Molecular Identities, and Functionality
by: Xueqing Liu, et al.
Published: (2019-01-01) -
Porphyromonas gingivalis affects neutrophil pro-inflammatory activities
by: Agnieszka Zimny, et al.
Published: (2025-01-01)